Dashboard
1
Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 2.93%
- Poor long term growth as Operating profit has grown by an annual rate 18.37% of over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.02
2
With ROE of -0.15%, it has a Very Expensive valuation with a 4.18 Price to Book Value
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.94%
0%
-5.94%
6 Months
9.9%
0%
9.9%
1 Year
58.04%
0%
58.04%
2 Years
13.1%
0%
13.1%
3 Years
3.51%
0%
3.51%
4 Years
-19.34%
0%
-19.34%
5 Years
90.0%
0%
90.0%
Medartis Holding AG for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.02%
EBIT Growth (5y)
18.37%
EBIT to Interest (avg)
1.02
Debt to EBITDA (avg)
0.12
Net Debt to Equity (avg)
-0.13
Sales to Capital Employed (avg)
0.63
Tax Ratio
Tax Ratio is Negative%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
2.93%
ROE (avg)
1.05%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.18
EV to EBIT
142.62
EV to EBITDA
35.48
EV to Capital Employed
4.14
EV to Sales
4.63
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
2.90%
ROE (Latest)
-0.15%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
212.00
182.80
15.97%
Operating Profit (PBDIT) excl Other Income
32.40
16.20
100.00%
Interest
1.70
4.60
-63.04%
Exceptional Items
-3.10
-0.90
-244.44%
Consolidate Net Profit
0.60
-5.80
110.34%
Operating Profit Margin (Excl OI)
54.00%
-10.20%
6.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 15.97% vs 14.32% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 110.34% vs -185.29% in Dec 2022
About Medartis Holding AG 
Medartis Holding AG
Pharmaceuticals & Biotechnology
Medartis Holding AG is a Switzerland-based holding company of the Medartis Group, which is engaged in manufacturing medical devices and implants. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. It has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.
Company Coordinates 
Company Details
Hochbergerstrasse 60E , BASEL None : 4057
Registrar Details






